NBB ... I think real data that is positive and significant, in humans regarding Covid, has the potential to gain a lot of visibility and interest ... Which is currently missing due to past failures in studies regarding "testing" of our theories. Especially if the Covid post-contraction Tx niche remains a need, and it will imho, as people will still get Covid even with vaccination growth, for various reasons including mutation.

I was extremely disappointed in our failure to lock down a partnership with a respected and influential BP also. That could have brought important and experienced new leadership, with a proven track record, in addition to alleviating the constant financial crisis as it appears to the investor community. Plus the newsworthy spotlighting and credibility effects.